Comprehensive meta-analysis linking phenolic acids to cardiometabolic health is currently lacking, but individual observational studies have reported that high intake was associated with lower odds of metabolic syndrome and elevated systolic blood pressure (SBP) (Reference Lanuza, Zamora-Ros and Bondonno10) , CVD (Reference Mara Mrida, Vitelli-Storelli and Moreno-Franco11,Reference Vzquez-Ruiz, Toledo and Vitelli-Storelli12) , non-alcohol fatty liver disease (NAFLD) and insulin resistance (Reference Salomone, Ivancovsky-Wajcman and Fliss-Isakov13)
Combining behavior change with GLP-1 is for many the key to creating healthy change that lasts
The difference between drawing 0.25 ml and 0.30 ml might look trivial on a syringe
J Neuroendocrinol 23(12):12881295
En la prctica, esto se traduce en unos 10-12 aos de exclusividad comercial efectiva una vez aprobado el medicamento
The balance matters because it shapes the biological response